Suboptimal Beta-Lactam Therapy in Critically Ill Children: Risk Factors and Outcome.

Tatjana Van Der Heggen, Evelyn Dhont, Jef Willems, Ingrid Herck, Joris R Delanghe, Veronique Stove, Alain G Verstraete, Sophie Vanhaesebrouck, Peter De Paepe, Pieter A J G De Cock

Journal: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2022;23(7):e309-e318

PMID: 35426861

Abstract

OBJECTIVES

In critically ill children, severely altered pharmacokinetics may result in subtherapeutic β-lactam antibiotic concentrations when standard pediatric dosing regimens are applied. However, it remains unclear how to recognize patients most at risk for suboptimal exposure and their outcome. This study aimed to: 1) describe target attainment for β-lactam antibiotics in critically ill children, 2) identify risk factors for suboptimal exposure, and 3) study the association between target nonattainment and clinical outcome.

DESIGN

Post hoc analysis of the "Antibiotic Dosing in Pediatric Intensive Care" study (NCT02456974, 2012-2019). Steady-state trough plasma concentrations were classified as therapeutic if greater than or equal to the minimum inhibitory concentration of the (suspected) pathogen. Factors associated with subtherapeutic concentrations and clinical outcome were identified by logistic regression analysis.

SETTING

The pediatric and cardiac surgery ICU of a Belgian tertiary-care hospital.

PATIENTS

One hundred fifty-seven patients (aged 1 mo to 15 yr) treated intravenously with amoxicillin-clavulanic acid, piperacillin-tazobactam, or meropenem.

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

Three hundred eighty-two trough concentrations were obtained from 157 patients (median age, 1.25 yr; interquartile range, 0.4-4.2 yr). Subtherapeutic concentrations were measured in 39 of 60 (65%), 43 of 48 (90%), and 35 of 49 (71%) of patients treated with amoxicillin-clavulanic acid, piperacillin-tazobactam, and meropenem, respectively. Estimates of glomerular filtration rate (eGFR; 54% increase in odds for each sd increase in value, 95% CI, 0.287-0.736; p = 0.001) and the absence of vasopressor treatment (2.8-fold greater odds, 95% CI, 1.079-7.253; p = 0.034) were independently associated with target nonattainment. We failed to identify an association between antibiotic concentrations and clinical failure.

CONCLUSIONS

Subtherapeutic β-lactam concentrations are common in critically ill children and correlate with renal function. eGFR equations may be helpful in identifying patients who may require higher dosing. Future studies should focus on the impact of subtherapeutic concentrations on clinical outcome.

Copyright © 2022 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Address: Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium.; Department of Basic and Applied Medical Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.; Department of Neonatology, University Medical Center, Utrecht, The Netherlands.; Department of Pediatric Intensive Care, Ghent University Hospital, Gent, Belgium.; Department of Intensive Care Medicine, Ghent University Hospital, Gent, Belgium.; Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.; Department of Pharmacy, Ghent University Hospital, Ghent, Belgium.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.